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Dynamic Analysis of Histamine-Mediated
Attenuation of Acetylcholine-Induced Sweating via
GSK3b Activation
Saki Matsui1, Hiroyuki Murota1, Aya Takahashi1, Lingli Yang1, Jeong-Beom Lee2, Kouta Omiya3,
Masato Ohmi3, Junichi Kikuta4, Masaru Ishii4 and Ichiro Katayama1
Sweating has been associated with the exacerbation of atopic dermatitis (AD) in diverse ways. Acetylcholine
(ACh)-mediated sweating is known to be attenuated in AD, but its cause remains obscure. To address this issue,
the impact of histamine on ACh-induced sweating was evaluated. Sweating was measured by counting the
number of active sweat pores by the starch–iodine reaction and dynamic optical coherence tomography; sweat
was visualized using two-photon excitation fluorescence microscopy in mice and the quantitative sudomotor
axon reflex test in humans. Both histamine receptor antagonists and H1 receptor (H1R)-knockout (KO) mice were
used to determine methodological specificity. Histamine demonstrably inhibited ACh-induced sweating in both
mice and humans via H1R-mediated signaling. In sweat glands, ACh inactivated glycogen synthase kinase 3b
(GSK3b), a kinase involved in endocytosis and secretion, whereas simultaneous stimulation with histamine
activated GSK3b. Results of two-photon excitation fluorescence microscopy confirmed the dynamic motion of
sweat and sweat glands after ACh treatment, showing that simultaneous stimulation with histamine altered
their dynamic properties. These results indicate that histamine inhibits sweat gland secretions by blocking
ACh-induced inactivation of GSK3b. Histamine-mediated hypohidrosis might be involved in the mechanism of
abnormal skin dryness in patients with AD.
Journal of Investigative Dermatology (2014) 134, 326–334; doi:10.1038/jid.2013.323; published online 29 August 2013
INTRODUCTION
Disturbances in the homeostatic function of the skin
evoke a variety of dermatoses. Sweating is involved in the
maintenance of skin homeostasis, with antimicrobial (Rieg
et al, 2005; Schittek et al, 2008) and moisturizing effects (Eishi
et al, 2002), and in the regulation of skin surface pH (Schmid-
Wendtner and Korting, 2006). Recent reports also suggest that
impaired sudomotor function contributes to the pathogenesis
of atopic dermatitis (AD) (Imayama et al, 1994; Eishi
et al, 2002; Kitaba et al, 2011; Shiohara et al, 2011; Kijima
et al, 2012), and agree that deterioration of sudomotor
function is found in patients with AD. These results indicate
that reduction of sweating might impair moisturization and
protection against infections of the skin. However, the
mechanism of aberrant sweating in AD remains unknown.
There are likely two hypotheses: the first is sweat duct
obstruction by abnormal keratinization (Sulzberger et al, 1947;
Papa and Kligman, 1966) and the second is abnormal sudomotor
function of sweat glands (Kijima et al, 2012). Because not all AD
patients with anhidrosis develop histopathological sweat duct
obstruction, we hypothesize that certain inflammatory mediators
might reduce the function of sweat glands. A potential candidate
for this hypothesis was histamine, which signals through a seven-
transmembrane receptor, as well as an acetylcholine (ACh)
receptor (Du Buske, 1996; Simons and Simons, 2011). It is
well known that antihistamines also have anticholinergic pro-
perties (Meltzer, 1990; Du Buske, 1996; Murota and Katayama,
2011). Thus, we evaluated the effects of histamine on
ACh-mediated sweating in animals.
Assessment of sudomotor function varies in methodology
and has been evaluated by visualization of the sweat response
by the iodine–starch reaction (Nejsum et al, 2002) or optical
coherence tomography (OCT) (Ohmi et al, 2009).
Here, we evaluated the impact of histamine on ACh-
mediated sweating using a multimodal approach in vivo,
and discuss the possible involvement of sudomotor dysfunc-
tion. Moreover, in this study, we attempted to visualize the
sweat response using two-photon excitation fluorescence
See related commentary on pg 302ORIGINAL ARTICLE
1Department of Dermatology, Course of Integrated Medicine, Graduate School
of Medicine, Osaka University, Osaka, Japan; 2Department of Physiology,
College of Medicine, Soonchunhyang University, Chenan, Republic of Korea;
3Course of Health Science, Graduate School of Medicine, Osaka University,
Osaka, Japan and 4Laboratory of Cellular Dynamics, WPI-Immunology Frontier
Research Center, Osaka University, Osaka, Japan
Correspondence: Hiroyuki Murota, Department of Dermatology, Course of
Integrated Medicine, Graduate School of Medicine, Osaka University, 2-2
Yamadaoka, Suita, Osaka 5650871 Japan.
E-mail: h-murota@derma.med.osaka-u.ac.jp
Received 31 March 2013; revised 29 May 2013; accepted 29 May 2013;
accepted article preview online 30 July 2013; published online 29 August
2013
Abbreviations: ACh, acetylcholine; AD, atopic dermatitis; ANOVA, analysis of
variance; GSK3a/b, glycogen synthase kinase 3a/b; H1R, histamine type-1
receptor; KO, knockout; M3R, muscarinic 3 receptor; OCT, optical coherence
tomography; QSART, quantitative sudomotor axon reflex test
326 Journal of Investigative Dermatology (2014), Volume 134 & 2014 The Society for Investigative Dermatology
microscopy and succeeded in obtaining the dynamic images
of sweat glands after sudomotor stimulation.
RESULTS
Validation of evaluation methodologies for ACh-mediated
sweating in mice
To demonstrate the validity of assessment of sudomotor
function in mice, four different methods were performed.
First, skin hydration was evaluated by the impedance method
based on the idea that sweat will moisten the skin surface
(Figure 1a). Skin hydration significantly increased on the ACh-
treated foot sole, but not on ACh-treated, sweat gland–free
back skin. The dynamic image of sweating obtained by OCT
revealed the increased sweat spout from the sweat duct on the
ACh-treated foot sole (Figure 1b and Supplementary Figure 1
online). The sudomotor reaction to ACh was also confirmed
by counting the number of iodine–starch reaction–positive
sweat pores (Figure 1c). These results indicate that our multi-
modal evaluations can adequately assess the sudomotor
reaction to ACh in vivo. Furthermore, two-photon microscopic
analysis revealed the three-dimensional structures of sweat
glands and microvessels visualized using anti-gross cystic
disease fluid protein antibody and intravenously administered
red fluorescent dextran, respectively (Figure 1d).
Effects of histamine on ACh-mediated sudomotor function
Histamine was administered simultaneously with ACh,
and sudomotor response was examined in mice. First, the
measurement results of skin hydration were increased by
stimulation with ACh alone, but there was no apparent
increase after coadministration of histamine with ACh
(Figure 2a). In the observation record of OCT, the number
of active sweat glands in ACh-treated mice decreased after
coadministration of histamine (Supplementary Figure 1B
and C online). High numbers of sweat pores positive for the
iodine–starch reaction by ACh treatment decreased after
coadministration of histamine (Figure 2b). To confirm which
type of histamine receptor has a crucial role in the suppression
of sudomotor function, antagonists for histamine receptors
(i.e., H1 receptor (H1R), H2R, and H4R) were administered
intraperitoneally (Figure 2b). Pyrilamine and fexofenadine,
H1R antagonists, decreased the ACh-induced sweating
response and prevented the histamine-mediated inhibition of
ACh-induced sweating. In contrast, both H2 and H4 receptor
antagonists markedly reduced ACh-induced sweating, but
did not affect the histamine-mediated inhibition of
ACh-induced sweating (Figure 2b). H1R-knockout (KO) mice
showed no apparent inhibition by histamine of increased
skin hydration (Figure 2c) and of increased number of iodine–
starch reaction–positive sweat pores by Ach treatment
(Figure 2d).
Localization of ACh and histamine receptors in the
microenvironment of the eccrine sweat gland
Next, to resolve the question of the unknown mechanism of
histamine-mediated inhibition of sweating, the localization of
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Figure 1. Multimodal approach to assess sudomotor response to acetylcholine (Ach) in vivo. (a) The degree of stratum corneum hydration was assessed with
conductance measurements. Left: foot sole, right: back skin. Statistical analysis was performed by one-way analysis of variance, Bonferroni’s multiple comparison test
(n¼ 5–6). (b) Dynamic images of sweating visualized by optical coherence tomography. Graph data show the quantification of the images (n¼5). (c) The result of
counting the number of iodine–starch reaction–positive sweat pores. **P¼0.003, unpaired t-test (n¼ 5–7). Arrows indicate the positive spots. (d) Observations with
two-photon microscopic analysis allowed a complete view of sweat glands. Green (FITC): gross cystic disease fluid protein (sweat gland); red (Texas Red): dextran
(microvessels).
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histamine or ACh receptors in the microenvironment of the
sweat gland was determined by immunohistochemical staining
(Figure 3 and Table 1). The muscarinic 3 receptor (M3R) was
chosen as the ACh receptor, because ACh receptors in mouse
eccrine sweat glands are predominantly M3R (Vilches et al,
1995). As a result, sweat glands expressed H1, H2, H4 and
M3 receptors. Protein gene product-9.5-positive peripheral
nerve fibers were co-stained with antibody against the H1,
H2, and M3 receptors, but myoepithelial cells did not stain with
antibodies against the H1, H2, H4, and M3 receptors. These
results suggest that there might be cross talk between two
distinct pathways downstream of histamine and ACh receptors
in sweat glands and nerve fibers.
Histamine blocks phosphorylation of glycogen synthase kinase
3b activated by ACh stimulation
A phosphorylation antibody array using whole-skin lysates was
used to examine the extent of cross talk between the histamine
and ACh signaling pathways (Figure 4a). We found two
candidate signal transducers, including glycogen synthase
kinase 3a/b (GSK3a/b) and AMP-activated protein kinase a1,
which were differentially phosphorylated by ACh and histamine
treatment (Figure 4a). GSK3a/b and AMP-activated protein
kinase a1 were phosphorylated by ACh alone, but not by
ACh plus histamine or histamine alone. Among these mole-
cules, we focused on GSK3b, which is thought to be involved
in cellular membrane transport and trafficking (Adachi et al,
2009, Rexhepaj et al, 2010). Such phosphorylation dynamics of
GSK3b were also observed in western blotting analysis
(Figure 4b). Immunohistochemical staining of phosphorylated
GSK3b was performed to confirm whether this cross talk
occurred in eccrine sweat glands. As a result, phosphorylation
of GSK3b was observed in sweat glands of ACh-treated skin,
but not in ACh- and histamine-treated skin (Figure 4c).
Histamine reduces the frequency of sweat secretion
As GSK3b is inactivated by phosphorylation, the adiaphoretic
effect of histamine was assumed to be due to decreased
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Figure 2. The effects of histamine (His) on sudomotor function. (a) The degree of stratum corneum hydration was assessed with conductance measurements
before (black circles) and after (black square) acetylcholine (Ach) administration with or without His. **Po0.01, two-way analysis of variance (ANOVA),
Bonferroni’s multiple comparison test (n¼ 5–6). (b) The result of counting the number of iodine–starch reaction–positive sweat pores with or without
administration of various antihistamines. Antagonists for H1R, H2R, and H4R were fexofenadine or pyrilamine, cimetidine, and JNJ7777120, respectively.
AH, antihistamine. ***Po0.001, *Po0.05, two-way ANOVA, Bonferroni’s multiple comparison test (n¼ 5–7). (c) The degree of stratum corneum hydration in
H1R-KO mice was assessed with conductance measurements before (black circles) and after (black square) Ach with or without His. ***Po0.001, *Po0.05,
two-way ANOVA, Bonferroni’s multiple comparison test (n¼ 5). (d) The results of counting the number of iodine–starch reaction–positive sweat pores in
H1R-KO mice. **Po0.01, *Po0.05, one-way ANOVA, Bonferroni’s multiple comparison test (n¼5–6).
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Figure 3. Localization of H1, H2, H4, and M3 receptors in the sweat gland microenvironment. Skin specimens derived from mice hindpaws were
immunohistochemically stained with antibodies against histamine receptors, SMA, protein gene product-9.5 (PGP-9.5), and M3 receptor. Bar¼ 100mm.
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secretion of sweat by activation of GSK3b. To confirm this
hypothesis, the dynamic imaging of sweat glands in mouse
hindpaws was observed using two-photon microscopy. In this
attempt, three-dimensional images of sweat glands and their
configuration were obtained. After 15 minutes of intraperito-
neal ACh administration, the sweat glands became distended
and contracted, followed by the appearance of optically
less-transparent areas, seen as ‘dark’ spots (Figure 5a and b
and Supplementary Figures 2A, B and 3A online). Although
we could not definitely identify the entity of the opaque
spots, we reasonably assumed that these spots are derived
from the change in local pH, that is, acidification due to
sweating (fluorescent intensity of fluorescein is known to be
critically dependent on the pH of the environment (Ohkuma
and Poole, 1978)).
In contrast to ACh administration, simultaneous intraperito-
neal administration of histamine decreased the number of
opaque spots (Figure 5a–c and Supplementary Figures 2C and
3B online).
Histamine decreases the ACh-induced, axon reflex–mediated
sweating volume in humans
The inhibitory effects of histamine on ACh-mediated sweating
in humans were assessed by quantitative sudomotor axon
reflex test (QSART) (Figure 6). When histamine was ionto-
phoretically applied with ACh simultaneously, QSART-mea-
sured results were significantly decreased compared with
results from stimulation solely with ACh.
DISCUSSION
The present study has partly revealed the mechanisms of
anhidrosis in AD using multiple assessments, showing that the
inhibitory effect of histamine on Ach-induced sweating
occurred via phosphorylation (inactivation) of GSK3b down-
stream of the H1R.
First, it was surprising that histamine has effects other than
induction of allergic inflammation. It has been reported that
histamine affects many kinds of cells, which express histamine
Table 1. Localization of H1R, H2R, H4R, and M3R on
eccrine sweat gland
H1R H2R H4R M3R
Sweat gland þ þ þ þ
Myoepithelial cell    
Nerve fiber þ þ  þ
Abbreviations: H1, 2, and 4R, type 1, 2, and 4 histamine receptor,
respectively; M3R, muscarinic 3 receptor.
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Figure 4. Cross talk between acetylcholine (Ach)- and histamine-mediated signal transduction. (a) Phosphorylation profiles of kinases and protein substrates in
Ach- or His-treated skin were analyzed with a phosphokinase antibody array. (b) Western blot analysis for phosphorylated GSK3b (p-GSK3b) and GSK3b.
The graph shows the relative levels of p-GSK3b (mean±SD). Signal intensity was determined by densitometry. Relative phosphorylation was calculated and
normalized against total amounts of GSK3b and quantified against the signal intensity of the control group. *Po0.05, two-way analysis of variance, Bonferroni’s
multiple comparison test (n¼3). A, acetylcholine; AþH, acetylcholineþ histamine; C, control; H, histamine. (c) Skin specimens derived from hindpaws
stimulated with ACh with or without histamine were immunohistochemically stained with anti-p-GSK3b and anti-SMA antibodies. Bar¼100mm.
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receptors. Previous studies also revealed that histamine is
involved in (1) waking mechanisms (Lin et al, 1988), cognitive
functioning (Gengo and Manning, 1990), and regulating the
level of food intake by affecting neuronal activity (Masaki
et al, 2004); (2) innate immune responses (Ertam et al, 2007;
Metz et al, 2011); and (3) induction of chemokines, cytokines,
and adhesion molecules on various types of cells (Fujikura
et al, 2001; Giustizieri et al, 2004; Murota and Katayama,
2011). However, as far as we know, the effects of histamine
on the sweating response have not been reported.
Recent reports shed light on the possible involvement of
decreased sweating in the pathogenesis of AD (Eishi et al,
2002; Shiohara et al, 2011; Kijima et al, 2012; Sugawara et al,
2012), but the mechanisms of hypohidrosis in AD remain
obscure. The pathogenic involvement of histamine in AD has
been discussed in past articles, as histamine was thought
to contribute to early events in AD (Akdis et al, 2006;
Vanbervliet et al, 2011). The results of our study suggest
that histamine might also impair skin homeostasis via
decreasing sweating volume. Decreased sweating is also
found in patients with urticaria, especially the cholinergic
type (Itakura et al, 2000; Kobayashi et al, 2002). Thus, it
might be said that sweating dysfunction may contribute to
histamine-related skin disorders.
Furthermore, we found that H1Rs had a crucial role in
histamine-mediated inhibition of ACh-induced sweating.
Administration of H1R antagonists in wild-type mice attenu-
ated the inhibitory effects of histamine on ACh-induced
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Figure 5. Dynamic imaging of sweat glands by two-photon microscopic analysis. (a) Acetylcholine (ACh) or ACh and histamine (AChþhistamine) were
intraperitoneally injected. Subsequently, the motion of the sweat glands was recorded for 30 minutes. Photos before treatment, 15 minutes, and 30 minutes after
observation are presented. Circles with a dotted line show the opaque spots that possibly suggest sweating. Bar¼ 50mm. (b) The number of low-density spots per
field per 30 minutes was counted. Bar¼ 500mm. Circles with a dotted line enclose the low-density spots. (c) The ratio of the number of sweat glands associated
with or without low-density spots is presented. **Po0.01, unpaired t-test (n¼5).
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sweating; similarly, H1R-KO mice showed diminished inhibi-
tion by histamine. As H1Rs are expressed in secretory sweat
glands and nerve fibers, histamine might affect both tissues.
These results indicate that H1R antagonists might have
potential therapeutic effects in allergic patients with anhidro-
sis. Unexpected results were obtained from the administration
of cimetidine and JN7777120; we found that these com-
pounds decreased ACh-induced sweating but did not increase
the low numbers of sweat pores positive for the iodine–starch
reaction. These results suggest that an H2R or H4R antagonist
might hold promise for treating hyperhidrosis. However, at
present, we cannot explain the mechanisms of such phenom-
ena; thus, further investigation is needed to clarify this issue.
We investigated the cross talk between the signaling path-
ways downstream of histamine and ACh, and found potential
signal transducers that were differently activated by histamine
or ACh. GSK3b is a Ser/Thr kinase with pleiotropic functions,
including glycogen metabolism, regulation of the cell cycle,
cell survival and differentiation, and inflammation (Doble and
Woodgett, 2003; Jope and Johnson, 2004; Wang et al, 2011);
it is phosphorylated in ACh-stimulated sweat glands. As
GSK3b is also known to participate in the regulation of both
cellular membrane transport and trafficking (Adachi et al,
2009; Rexhepaj et al, 2010), it is possible that GSK3b could be
involved in sweat secretion (Supplementary Figure 4 online).
When necessary, ACh causes the inactivation (phosphoryla-
tion) of GSK3b, stimulating sweat secretion. Histamine might
inhibit ACh-induced sweat secretion by leading to the depho-
sphorylation (activation) of GSK3b. Previous reports about the
function of GSK3b in glomerular filtration provide collateral
evidence for this hypothesis. Mice with aberrantly activated
GSK3b (gskKI) develop increased body temperature, food
and water intake, glomerular filtration rate, urinary flow rate,
urine osmolarity, urinary Naþ and Kþ , urea excretion, and
proteinuria (Boini et al, 2008; Boini et al, 2009). Thus, it is
easy to assume that activation of GSK3b might be involved
in sweat secretion and glomerular filtration. This idea is
supported by the dynamic images of sweat glands with
two-photon microscopic analysis. To our knowledge, the
real-time motion of sweat glands was previously unreported.
The present study also revealed the inhibitory effects of
histamine on GSK activation. As certain antihistamines affect
glomerular filtration and renal function (Chansel et al, 1982;
Abboud, 1983; Radke et al, 1985), histamine might affect the
properties of secretory glands throughout the body.
AMP-activated protein kinase a1, a key regulator of intracel-
lular fatty acid metabolism, is activated by increasing intracel-
lular AMP levels (Liu et al, 2006); it is also inactivated by
histamine administration. Unfortunately, although we could not
confirm the function of AMP-activated protein kinase a1 in
sweat glands, there is still the possibility that AMP-activated
protein kinase a1 is involved in ACh-induced cAMP
accumulation in sweat glands (Sato and Sato, 1983; 1987).
Such attractive result should be confirmed elsewhere.
Dysfunctional sweating responses are not only problems for
allergic dermatoses but also big problems for many types of
diseases, including idiopathic anhidrosis or hyperhidrosis.
Although these diseases strongly impair patients’ quality-of-life,
as well as activities of daily living, it should be said that there
are no promising therapeutic methods for these diseases. We
believe that this report may provide the basis of understanding
the mechanisms involved and contribute to formulating ther-
apeutic strategies for diseases involving sudomotor dysfunction.
MATERIALS AND METHODS
Animals
Ten- to twelve-week-old female C57BL/6J (C57BL/6) mice (10–12
weeks of age, weighing 20–30 g) were purchased from Clea (Osaka,
Japan). H1R-KO (Hrh1 KO) mice were purchased from Oriental Bio
Service (Kyoto, Japan). Mice were maintained in our pathogen-free
animal facility. All animal care was in accordance with the institu-
tional guidelines of Osaka University.
Preparation of reagents
ACh (pilocarpine hydrochloride; Junsei Chemical, Tokyo, Japan) and
histamine (histamine diphosphate; Wako Pure Chemical Industries,
Osaka, Japan) were dissolved in phosphate-buffered saline on the day
of the experiment. Iodine (Sigma-Aldrich) was dissolved in ethanol
(5% w/v) and starch (Wako Pure Chemical Industries) was diluted in
mineral oil (nacalai tesque) (0.5% w/v).
In vivo sweat response
ACh-induced sweating was measured by both counting the spots in the
starch–iodine reaction and measuring skin conductance to evaluate the
number of active sweat glands and sweat volume, respectively.
The starch–iodine reaction was carried out using a slightly modi-
fied method from a previous report (Nejsum et al, 2002). Mice
were anesthetized with intraperitoneal injection of a mixture of three
drugs, 0.3 mg kg 1 domitor, 5 mg kg 1 vetorphale, and 4 mg kg 1
dormicum. Mouse hindpaws were painted with 3.5% iodine in
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ethanol and 10% starch solution in mineral oil. Subsequently,
subcutaneous injection with 20ml phosphate-buffered saline
(vehicle), 50mg/20ml ACh, and 120mg/20ml histamine was perfor-
med. The control group was the nontreated group. Each group
consisted of 3–6 mice. Two minutes after injection, the treated
hindpaws were photographed, and black spots caused by the amylase
reaction (i.e., iodine and starch response) were counted.
Optical coherence tomography
Because there is a large refractive index difference on the wall of the
spiral lumen between the sweat and keratinous epidermal tissues, the
eccrine sweat ducts in the stratum corneum of the epidermis are
clearly recognized by a spiral lumen with a high reflective light
intensity. The dynamic OCT images of Ach-induced sweating in the
x–z plane were obtained from B-mode OCT. The administration
methods for vehicle, ACh, and histamine were the same as in the
starch–iodine reaction test.
Two-photon excitation fluorescence microscopy
Intravital multiphoton imaging of sweat glands in the skin was
performed using previously described protocols (Ishii et al, 2009)
with modifications. Mice were anesthetized with isoflurane (Escain;
2.0% vaporized in 100% oxygen). Skin was observed with an inverted
multiphoton microscope (A1R-MP; Nikon, Tokyo, Japan) driven by a
Ti:Sapphire laser (Chameleon Vision II; Coherent, Santa Clara, CA)
tuned to 800 nm and an inverted microscope equipped with multi-
immersion objectives (CFI-Plan-Fluor,  20/N.A. 0.75; Nikon). Sweat
glands were visualized by anti-M3 antibody staining, and blood vessels
were visualized using Texas Red-labeled 70-kDa dextran. To detect
second harmonic-generated (ch1), FITC (ch2), Red (ch3), and Far Red
(ch4) emission signals, 492 nm short pass, 500/50 nm, 562/25 nm, and
601/56 nm bandpass filters were used, respectively. Raw imaging data
were processed with Volocity three-dimensional image analysis
software (PerkinElmer, Waltham, MA). Sweat glands, microvessels,
and nuclei were stained with FITC-conjugated anti-gross cystic disease
fluid protein antibody or anti-aquaporin5 antibody, Texas Red-
conjugated 70-kDa dextran, and Hoechst 33342, respectively.
Phosphorylation antibody array
Skin samples of mice hindpaws were obtained immediately after
subcutaneous injection of Ach with or without histamine, or vehicle.
Samples were lysed in buffer containing phosphatase inhibitor. The
Phospho-Kinase-Array kit (proteome profiler antibody array; R&D Systems,
Minneapolis, MN) was used according to the manufacturer’s instructions.
Histamine antagonism
For histamine antagonism, 15 minutes before subcutaneous
injection of ACh or histamine, mice were injected intraperitoneally
with pyrilamine (700mg per body), fexofenadine hydrochloride
(600mg per body), and cimetidine (400mg per body).
Quantitative sudomotor axon reflex test
This study was approved by the Institutional Review Board of Osaka
University hospital (ID: UMIN000009247). Healthy volunteers were
enrolled in this study after obtaining a written informed consent and
providing written and oral information to the study physicians. This
study was performed in adherence with the guidelines of the
Declaration of Helsinki.
An examination was performed on the basis of the method
established by Lee et al (2009) (Kijima et al, 2012). Briefly, the
subjects were asked to remain quiet for 60 minutes before undergoing
QSART in a hospital outpatient clinic at constant temperature (20 1C)
and humidity (60%). The sweat volume–measuring capsule and
digital analyzer of measured sweat volume (SKINOS SKD-2000,
Nagano, Japan) were used in QSART. ACh (100 mg ml 1) with or
without histamine (0.1B1% w/v) was iontophoretically applied to the
skin from the outer compartment, whereas the glands of the skin in
the central compartment of the capsule were activated indirectly via
an axon reflex sweating. The axon reflex sweating volume was
measured during the 5 minutes of iontophoresis. Data for DIR
sweating were obtained over the subsequent 5 minutes.
Histological analysis
Paraffin-embedded samples of hindpaw skin were cut to 4-mm thick
sections. The antibodies used were rabbit anti-M3 (Abcam,
Cambridge, UK), goat anti-H1R, -H2R, and -H4R (all from Santa
Cruz Biotechnology, Santa Cruz, CA), anti-protein gene product-9.5
(Chemicon; AB1761), and anti-SMA (Santa Cruz Biotechnology)
antibodies. Secondary antibodies used were anti-rabbit and anti-goat
conjugated to Alexa Fluor 488 (Invitrogen, Carlsbad, CA), and
anti-rabbit and mouse antibodies conjugated to Alexa Fluor 555
(Invitrogen). Images of immunolabeled sections were captured with a
BZ-8000 microscope (Keyence, Osaka, Japan).
Western blot analysis
Skin samples were crushed in liquid nitrogen and solubilized at 4 1C
in lysis buffer (0.5% sodium deoxycholate, 1% Nonidet P40, 0.1%
sodium dodecyl sulfate, 100mg ml 1 phenylmethylsulphonyl fluor-
ide, 1 mM sodium orthovanadate, and protease inhibitor cocktail).
The protein extracts (20mg each) were analyzed with an anti-
phospho-GSK3a/b antibody (no. 9331, Cell Signaling Technology,
Danvers, MA). An anti-GSK3a/b antibody (no. 5676; Cell Signaling
Technology) was used as a control. Protein bands were detected using
the ECL Plus kit (GE Healthcare, Buckinghamshire, UK). GSK3b was
detected as two bands around 45 kDa. The intensity of the bands was
quantified by using NIH image J software.
Statistic analysis
Prism5 software (GraphPad Software, La Jolla, CA) was used for
statistical analysis. Statistical significance was examined by unpaired
t-test or Bonferroni’s multiple comparison test. Graph bars represent the
mean±SD. *Po0.05, **Po0.01, ***Po0.001, and ****Po0.0001.
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